Key result
Advances in genomic science and genome-wide SNP analyses offer novel strategies to identify genetic contributors to sudden cardiac death susceptibility and discover new therapeutic targets.
Design
Review
Authors
Loading...
Rising SCD rates despite falling cardiac mortality highlight need for improved risk stratification; leaves open precise phenotyping of high-risk patients.
Advances in genomic science, including novel bioinformatic approaches and genome-wide SNP analyses, offer promising strategies to identify genetic contributors to sudden cardiac death and discover new therapeutic targets.
Arking et al. (2004) conducted a review in Sudden cardiac death. Genomic science was evaluated. Advances in genomic science and genome-wide SNP analyses offer novel strategies to identify genetic contributors to sudden cardiac death susceptibility and discover new therapeutic targets.